Kim Lorence H.
SEC Form 4 insider trading activity
Kim Lorence H. has filed 4 SEC Form 4 filings (16 transaction rows) across 2 companies, including RVMD, COR, with disclosures dating back to 2026. 4 of those filings fall inside the rolling window. Most recent filing: Sep 10, 2026.
On the most recent filing, Kim Lorence H. is listed as Director at Revolution Medicines, Inc. Inside the rolling window, Kim Lorence H. reported no open-market purchases and 2 open-market sales totaling $15.0M in RVMD. The largest disclosed transaction in the window is a sale of 56,000 RVMD shares on Aug 31, 2026, worth $11.4M.
Companies traded
Other insiders at RVMD
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$15.0M
reported sales (SEC code S)
Companies
2
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Kim Lorence H. made?
Kim Lorence H. has filed 4 SEC Form 4 filings (16 transaction rows) across 2 companies, including RVMD, COR since 2026.
Which companies does Kim Lorence H. trade?
Kim Lorence H. has filed SEC Form 4 disclosures for 2 companies, including RVMD, COR.
When was Kim Lorence H.'s most recent SEC Form 4 filing?
Kim Lorence H.'s most recent SEC Form 4 filing on Tracefour is dated Sep 10, 2026.
What is Kim Lorence H.'s total buy and sell value in the current window?
Inside the rolling retention window, Kim Lorence H. bought $0 and sold $15.0M based on SEC Form 4 filings.
What was Kim Lorence H.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 56,000 RVMD shares on 2026-08-31, worth $11.4M, per SEC Form 4 filings.